PRVA
Get informed when a big investor buys or sells
+ FollowUndervalued by 100% based on the discounted cash flow analysis.
| Market cap | $2.98 Billion |
|---|---|
| Enterprise Value | $-407,520,287,107.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.19 |
| Beta | 0.84 |
| Outstanding Shares | 124,153,000 |
| P/E Ratio | 133.8 |
|---|---|
| PEG | 0.18 |
| Price to Sales | 1.32 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -181.39 |
| Enterprise Value to EBIT | -9818.11 |
| Enterprise Value to Net Income | -34 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 4.30%▼ 93.06% |
|---|---|
| Total Invested | $137.41M▼ 94.47% |
| Investors Holding | 67▼ 229.00% |
No data
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for del...